These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 9742917)
1. Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer. Yu W; Whang I; Suh I; Averbach A; Chang D; Sugarbaker PH Ann Surg; 1998 Sep; 228(3):347-54. PubMed ID: 9742917 [TBL] [Abstract][Full Text] [Related]
2. Indications for early postoperative intraperitoneal chemotherapy of advanced gastric cancer: results of a prospective randomized trial. Yu W; Whang I; Chung HY; Averbach A; Sugarbaker PH World J Surg; 2001 Aug; 25(8):985-90. PubMed ID: 11571980 [TBL] [Abstract][Full Text] [Related]
3. Early postoperative intraperitoneal chemotherapy with mitomycin C, 5-fluorouracil and cisplatin for advanced gastric cancer. Noh SH; Yoo CH; Chung HC; Roh JK; Shin DW; Min JS Oncology; 2001; 60(1):24-30. PubMed ID: 11150904 [TBL] [Abstract][Full Text] [Related]
4. A review of adjuvant therapy for resected primary gastric cancer with an update on Taegu's phase III trial with intraperitoneal chemotherapy. Yu W Eur J Surg Oncol; 2006 Aug; 32(6):655-60. PubMed ID: 16618532 [TBL] [Abstract][Full Text] [Related]
5. Upper abdominal stop-flow perfusion as a neo and adjuvant hypoxic regional chemotherapy for resectable gastric carcinoma. A prospective randomized clinical trial. Lygidakis NJ; Sgourakis G; Aphinives P Hepatogastroenterology; 1999; 46(27):2035-8. PubMed ID: 10430393 [TBL] [Abstract][Full Text] [Related]
6. Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer. Lise M; Nitti D; Marchet A; Sahmoud T; Buyse M; Duez N; Fiorentino M; Dos Santos JG; Labianca R; Rougier P J Clin Oncol; 1995 Nov; 13(11):2757-63. PubMed ID: 7595735 [TBL] [Abstract][Full Text] [Related]
8. A controlled clinical study of serosa-invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermo-chemo-perfusion (IHCP). Kim JY; Bae HS Gastric Cancer; 2001; 4(1):27-33. PubMed ID: 11706624 [TBL] [Abstract][Full Text] [Related]
9. Palliation with a glimmer of hope: management of resectable gastric cancer with peritoneal carcinomatosis. Sugarbaker PH; Yonemura Y Hepatogastroenterology; 2001; 48(41):1238-47. PubMed ID: 11677938 [TBL] [Abstract][Full Text] [Related]
10. Perioperative chemotherapy versus postoperative chemoradiotherapy in patients with resectable gastric/gastroesophageal junction adenocarcinomas: A survival analysis of 5058 patients. Fitzgerald TL; Efird JT; Bellamy N; Russo SM; Jindal C; Mosquera C; Holliday EG; Biswas T Cancer; 2017 Aug; 123(15):2909-2917. PubMed ID: 28386965 [TBL] [Abstract][Full Text] [Related]
11. Adjuvant intraperitoneal cisplatin chemotherapy does not improve long-term survival after surgery for advanced gastric cancer. Sautner T; Hofbauer F; Depisch D; Schiessel R; Jakesz R J Clin Oncol; 1994 May; 12(5):970-4. PubMed ID: 8164049 [TBL] [Abstract][Full Text] [Related]
13. Morbidity and mortality of early postoperative intraperitoneal chemotherapy as adjuvant therapy for gastric cancer. Yu W; Whang I; Averbach A; Chang D; Sugarbaker PH Am Surg; 1998 Nov; 64(11):1104-8. PubMed ID: 9798779 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant intraperitoneal chemotherapy with carbon-adsorbed mitomycin in patients with gastric cancer: results of a randomized multicenter trial of the Austrian Working Group for Surgical Oncology. Rosen HR; Jatzko G; Repse S; Potrc S; Neudorfer H; Sandbichler P; Zacherl J; Rabl H; Holzberger P; Lisborg P; Czeijka M J Clin Oncol; 1998 Aug; 16(8):2733-8. PubMed ID: 9704725 [TBL] [Abstract][Full Text] [Related]
15. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1. Nashimoto A; Nakajima T; Furukawa H; Kitamura M; Kinoshita T; Yamamura Y; Sasako M; Kunii Y; Motohashi H; Yamamoto S; J Clin Oncol; 2003 Jun; 21(12):2282-7. PubMed ID: 12805327 [TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination. Fujiwara Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Okada K; Mori M; Doki Y Ann Surg Oncol; 2011 Dec; 18(13):3726-31. PubMed ID: 21584835 [TBL] [Abstract][Full Text] [Related]
17. [The optimal period for orally administered fluoropyrimidines as an adjuvant chemotherapy for gastric cancer--a pilot study using 5-FU tablets compared with surgical operation alone]. Fujii M; Sakabe T; Wakabayashi K; Kochi M; Mochizuki F; Kasakura Y; Yamagata M; Noro M; Osawa T; Iwai S Gan To Kagaku Ryoho; 1994 Jul; 21(8):1199-208. PubMed ID: 8031162 [TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant treatment of gastric cancer with peritoneal dissemination. Yonemura Y; Bandou E; Sawa T; Yoshimitsu Y; Endou Y; Sasaki T; Sugarbaker PH Eur J Surg Oncol; 2006 Aug; 32(6):661-5. PubMed ID: 16621433 [TBL] [Abstract][Full Text] [Related]
19. Results of immunochemo-surgery for gastric carcinoma. Kim JP; Yu HJ; Lee JH Hepatogastroenterology; 2001; 48(41):1227-30. PubMed ID: 11677936 [TBL] [Abstract][Full Text] [Related]
20. Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study. Yonemura Y; de Aretxabala X; Fujimura T; Fushida S; Katayama K; Bandou E; Sugiyama K; Kawamura T; Kinoshita K; Endou Y; Sasaki T Hepatogastroenterology; 2001; 48(42):1776-82. PubMed ID: 11813623 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]